HLA-G expression in human ovarian carcinoma counteracts NK cell function.

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

Volumn 18, Issue 11, 2007, Pages 1804-1809

  Lin, A ^a   Yan, W H ^a   Xu, H H ^a   Gan, M F ^a   Cai, J F ^a   Zhu, M ^a   Zhou, M Y ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; HLA-G ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; NEEDLE BIOPSY; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

BIOPSY, NEEDLE; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; OVARIAN NEOPLASMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 38449107523     PISSN: None     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm356     Document Type: Article

References (0)